olcegepant
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Olcegepant (BIBN4096BS) is a selective non‐peptide CGRP receptor antagonist with acute antimigraine properties. Since systemic…
Previous data showed that, in rats, anti‐migraine drugs (triptans, olcegepant) significantly reduced mechanical allodynia induced…
L-type calcium channel blockers like verapamil are used in the prophylaxis of migraine. However, their effect on the expression…
Migraine is a complex, neurovascular disorder in which genetic and environmental factors interact. At present, frontline…
The neuropeptide calcitonin gene‐related peptide (CGRP) is implicated in the underlying pathology of migraine. Serum levels of…
Migraine is a complex neurological disorder in which genetic and environmental factors interact. At present, frontline therapies…
Vasoconstriction to agonists at serotonin (5-hydroxytryptamine; 5-HT) receptors and α-adrenoceptors, as well as vasodilatation…
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…